Clinical Trial

Effect of Procyanidins in Leaky Gut Repairing in IBD

Study acronym: EcoVitis
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn if the Grape Seed Extract Ecovitis, featuring low monomeric catechins content and a high concentration of oligo-polymeric procyanidins, could modulate the Gut Microbiota composition of Ulcerative Colitis patients during the remission phase. The main questions it aims to answer are: Does Ecovitis improve the microbiota composition in patients with Ulcerative colitis? Is the intestinal permeability affected? What about the variation in the quality of life? Participants will: Take 2 capsules/day of Ecovitis for eight weeks Visit the clinic two times for checkups, serum collection, and Questionaire.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-26.
Trial Details
NCT Number NCT06576700
Lead Sponsor University of Padova
Conditions Ulcerative Colitis in Remission
Enrollment 25 participants
Start Date 2024-06-15
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-06-12 (estimated)
Updated on ClinicalTrials.gov 2024-09-19